The impact of chemotherapy on ovarian reserve in patients with molar pregnancy

Not Applicable

• Conditions: Condition 1: Hydatidiform mole. Condition 2: molar pregnancy.; Neoplasm of uncertain or unknown behaviour: Placenta; Pregnancy,; Hydatidiform mole, unspecified; Neoplasms

• Registration Number: IRCT201104165810N2
• Lead Sponsor: Private

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 70

Inclusion Criteria

Patient between the ages of 18-45 years who confirmed the molar pregnancy with pathology
exclusion criteria: 1- Endocrine diseases 2- History of ovarian surgery

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Anti mullerian hormone. Timepoint: before suction curttage- after zero beta titrage. Method of measurement: ELISA.